Royalty Pharma Cash Flow from Operating Activities 2019-2025 | RPRX
Royalty Pharma cash flow from operating activities for the twelve months ending March 31, 2025 was $6.714B, a 10.59% decline year-over-year.
- Royalty Pharma annual cash flow from operating activities for 2024 was $2.769B, a 7.32% decline from 2023.
- Royalty Pharma annual cash flow from operating activities for 2023 was $2.988B, a 39.36% increase from 2022.
- Royalty Pharma annual cash flow from operating activities for 2022 was $2.144B, a 6.27% increase from 2021.